Do You Know The Most Common Biologics For Arthritis ?

Overview of the most common biologic medications used to treat rheumatoid arthritis, including TNF Alpha inhibitors, IL-6 inhibitors, CD20 inhibitors, and JAK inhibitors.

Ask about this video. Answers come from its transcript only — with the timestamp, so you can check them.

Generated from the transcript and can be wrong — check the timestamp.

Key Takeaways

TNF Alpha inhibitors are the most commonly used biologics for rheumatoid arthritis.
IL-6 inhibitors and CD20 inhibitors provide alternative mechanisms of action.
JAK inhibitors represent a newer class of oral medications for rheumatoid arthritis.
Knowing the medication classes helps in understanding treatment options.
Biologics target specific immune system components to reduce arthritis inflammation.

What the video covers

The video discusses common biologic medications for rheumatoid arthritis treatment.
TNF Alpha inhibitors include adalimumab (Humira), etanercept (Enbrel), golimumab (Simponi), certolizumab (Cimzia), and infliximab (Remicade).
IL-6 inhibitors mentioned are tocilizumab (Actemra) and sarilumab (Kevzara).
CD20 inhibitors include rituximab (Rituxan).
JAK kinase inhibitors include tofacitinib (Xeljanz), baricitinib (Olumiant), and upadacitinib (Rinvoq).
Each class targets specific molecules or pathways involved in rheumatoid arthritis inflammation.
The video provides examples of brand and generic names for each medication class.
These biologics are used to manage symptoms and progression of rheumatoid arthritis.
The transcript contains some transcription errors but the key medication names and classes are clear.

What are the main classes of biologic medications used for rheumatoid arthritis?

The main classes include TNF Alpha inhibitors, IL-6 inhibitors, CD20 inhibitors, and JAK kinase inhibitors, each targeting different molecules involved in inflammation.

Can you name some examples of TNF Alpha inhibitors?

Examples of TNF Alpha inhibitors are adalimumab (Humira), etanercept (Enbrel), golimumab (Simponi), certolizumab (Cimzia), and infliximab (Remicade).

What are JAK inhibitors and which ones are commonly used?

JAK inhibitors are a class of oral medications that block Janus kinase enzymes involved in immune signaling. Common examples include tofacitinib (Xeljanz), baricitinib (Olumiant), and upadacitinib (Rinvoq).

Full Transcript — Download SRT & Markdown

00:00

Speaker A

What are the most common biologic medications used in rheumatoid arthritis patients? For patients with rheumatoid arthritis, here are the classes of medications that we currently use. The TNF Alpha inhibitors that will inhibit TNF Alpha molecules, and I will give you some examples. Adalimumab or Humira, etanercept or Enbrel, golimumab or Simponi, certolizumab or Cimzia, infliximab or Remicade. Another class, IL-6 inhibitors, that will inhibit IL-6 molecules like tocilizumab or Actemra and sarilumab or Kevzara. Another class are CD20 inhibitors, and here we have rituximab or Rituxan. The JAK kinase inhibitors or the JAK inhibitors like tofacitinib or Xeljanz, baricitinib or Olumiant, and upadacitinib or Rinvoq.

00:19

Speaker A

examples adalum or Huma acept or embil golimumab or Symphony cimap or simia infliximab or remig gate another class il6 Inhibitors that will inhibit il6 molecules like tossil orra and sarilumab or Kara another class are C for Inhibitors and here we have a basp

00:46

Speaker A

or orenia the Jack kise Inhibitors or the Jack Inhibitors like the Fatin or zelens V or aluman and C or Rog

Topics:rheumatoid arthritisbiologicsTNF Alpha inhibitorsIL-6 inhibitorsCD20 inhibitorsJAK inhibitorsadalimumabtocilizumabrituximabtofacitinib

Key Takeaways

What the video covers

Questions about this video

Full Transcript — Download SRT & Markdown

Get More with the SozAI App

Do You Know The Most Common Biologics For Arthritis ?

Key Takeaways

What the video covers

Questions about this video

Full Transcript — Download SRT & Markdown

Get More with the SozAI App

More from Dr. Diana Girnita - Rheumatologist OnCall